Registration number: 14216597

Essex and Suffolk Equine Vets Ltd

Contents

Abridged Balance Sheet	1 to 2
Notes to the Unaudited Abridged Financial Statements	3 to 4

Essex and Suffolk Equine Vets Ltd

(Registration number: 14216597)
Abridged Balance Sheet as at 30 September 2024

	Note	2024 £	2023 £
Fixed assets
Tangible assets	4	230,535	174,337
Current assets
Stocks		51,533	36,345
Debtors		84,233	51,632
Cash at bank and in hand		290,306	245,313
		426,072	333,290
Creditors: Amounts falling due within one year		(201,297)	(220,715)
Net current assets		224,775	112,575
Total assets less current liabilities		455,310	286,912
Creditors: Amounts falling due after more than one year		(50,529)	(73,554)
Provisions for liabilities		(53,613)	(34,978)
Net assets		351,168	178,380
Capital and reserves
Called up share capital		3	1
Profit and loss account		351,165	178,379
Total equity		351,168	178,380

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Essex and Suffolk Equine Vets Ltd

(Registration number: 14216597)
Abridged Balance Sheet as at 30 September 2024

Approved and authorised by the Board on 3 April 2025 and signed on its behalf by:
 

Mr B K Payne

Director

Ms K Church

Director

Mr B L Gibson

Director

Essex and Suffolk Equine Vets Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2024

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the Board on 3 April 2025.

2	Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis. Of the company's current liabilities at 30 September 2024, an amount is owed to the directors, who have agreed to continue to support the company, and not to demand repayment of this amount to the extent that any such repayment would jeopardise the future of the company.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Essex and Suffolk Equine Vets Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Land and buildings	2% Straight Line
Motor vehicles	25% Reducing Balance
Plant and machinery	25% Straight Line
Fixtures and fittings	25% Straight Line
Office equipment	25% Straight Line

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 9 (2023 - 4).

4	Tangible assets

	Total £
Cost or valuation
At 1 October 2023	213,986
Additions	123,818
At 30 September 2024	337,804
Depreciation
At 1 October 2023	39,649
Charge for the year	67,620
At 30 September 2024	107,269
Carrying amount
At 30 September 2024	230,535
At 30 September 2023	174,337

5	Related party transactions

Advances to directors

Mr B L Gibson During the period Mr B L Gibson went overdrawn on their director's loan account. The maximum overdrawn balance during the year was £18,600 (2023 - £Nil). At the year end the amount outstanding from Mr B L Gibson was £Nil (2023 - £Nil). Interest has been charged at the commercial rate.